Publications by authors named "Sergio Dubner"

Claim this Profile
I
Implantable Cardioverter-Defibrillators in Chagas Cardiomyopathy.
Sergio J Dubner

JAMA Cardiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early warning of atrial fibrillation using deep learning.
Marino Gavidia, Hongling Zhu, Arthur N Montanari, Jesús Fuentes, Cheng Cheng, Sergio Dubner

Patterns (N Y)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).
Irina Savelieva, Stefano Fumagalli, Rose Anne Kenny, Stefan Anker, Athanase Benetos, Sergio Dubner

Europace· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program.
Lea Beier, Shihai Lu, Lionel Riou França, Sabrina Marler, Gregory Y H Lip, Sergio J Dubner

PLoS One· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry.
Menno V Huisman, Christine Teutsch, Shihai Lu, Hans-Christoph Diener, Sergio J Dubner

Clin Res Cardiol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.
Gregory Y H Lip, Agnieszka Kotalczyk, Christine Teutsch, Hans-Christoph Diener, Sergio J Dubner

Clin Res Cardiol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.
Gregory Y H Lip, Agnieszka Kotalczyk, Christine Teutsch, Hans-Christoph Diener, Sergio J Dubner

Clin Res Cardiol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of adult, child and newborn cardiac arrest victims with COVID-19. Recommendations from the Interamerican Society of Cardiology / Sociedad Interamericana de Cardiología (SIAC), Mexican National Cardiologists Association / Asociación Nacional de Cardiólogos de México (ANCAM) and Mexican Society of Cardiology / Sociedad Mexicana de Cardiología (SMC).
Humberto Rodríguez-Reyes, Fernando Ortiz-Galván, Martín Ibarrola, Manuel Celaya-Cota, Sergio Dubner

Arch Cardiol Mex· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catheter ablation of ventricular tachycardia in patients with electrical storm, with a special focus on patients with Chagas disease.
Claudio Hadid, Darío Di Toro, Leonardo Celano, Nicolas Martinenghi, Edgar Antezana-Chaves, Sergio Dubner

J Interv Card Electrophysiol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study.
Sake J van der Wall, Gregory Y H Lip, Christine Teutsch, Oskars Kalejs, Philippe Lyrer, Sergio J Dubner

Eur J Intern Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A counterpoint paper: Comments on the electrocardiographic part of the 2018 Fourth Universal Definition of Myocardial Infarction.
Yochai Birnbaum, Miguel Fiol, Kjell Nikus, Javier Garcia Niebla, Ljuba Bacharova, Sergio Dubner

J Electrocardiol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AF.
Sake J van der Wall, Christine Teutsch, Sergio J Dubner, Hans-Christoph Diener, Jonathan L Halperin

TH Open· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of dabigatran in Latin American patients with atrial fibrillation: Two years follow up results from GLORIA-AF registry.
Sergio Dubner, José Francisco Kerr Saraiva, Juan Carlos Nunez Fragoso, Gonzalo Barón-Esquivias, Christine Teutsch

Int J Cardiol Heart Vasc· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF.
Sergio J Dubner, Christine Teutsch, Menno V Huisman, Hans-Christoph Diener, Jonathan Halperin

ESC Heart Fail· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A counterpoint paper: Comments on the electrocardiographic part of the 2018 Fourth Universal Definition of Myocardial Infarction endorsed by the International Society of Electrocardiology and the International Society for Holter and Noninvasive Electrocardiology.
Yochai Birnbaum, Miguel Fiol, Kjell Nikus, Javier Garcia Niebla, Ljuba Bacharova, Sergio Dubner

Ann Noninvasive Electrocardiol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA-AF registry.
Changsheng Ma, Lionel Riou França, Shihai Lu, Hans-Christoph Diener, Sergio J Dubner

J Arrhythm· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up.
Monika Kozieł, Michał Mazurek, Christine Teutsch, Hans-Christoph Diener, Sergio J Dubner

J Clin Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry.
Miney Paquette, Lionel Riou França, Christine Teutsch, Hans-Christoph Diener, Shihai Lu, Sergio J Dubner

Am J Cardiol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme.
Michał Mazurek, Jonathan L Halperin, Menno V Huisman, Hans-Christoph Diener, Sergio J Dubner

Europace· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program.
Michał Mazurek, Christine Teutsch, Hans-Christoph Diener, Sergio J Dubner, Jonathan L Halperin

Am Heart J· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Edoxaban in Latin America.
Sergio J Dubner, Nicolas Martinenghi

J Am Coll Cardiol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program.
Michał Mazurek, Menno V Huisman, Kenneth J Rothman, Miney Paquette, Christine Teutsch, Sergio J Dubner

Am J Med· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry.
Menno V Huisman, Kenneth J Rothman, Miney Paquette, Christine Teutsch, Hans-Christoph Diener, Sergio J Dubner

Am Heart J· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry.
Michał Mazurek, Menno V Huisman, Kenneth J Rothman, Miney Paquette, Christine Teutsch, Sergio J Dubner

Thromb Haemost· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation.
Miney Paquette, Lionel Riou França, Christine Teutsch, Hans-Christoph Diener, Shihai Lu, Sergio J Dubner

J Am Coll Cardiol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis